Anagliptin / Metformin Hydrochloride Tablets 100mg/500mg (Metoana HD® / メトアナ配合錠HD)

JPY ¥30,000

Japanese selective DPP-4 inhibitor/biguanide combination agent (Anagliptin 100mg / Metformin Hydrochloride 500mg). Oral tablets for the treatment of type 2 diabetes mellitus. 100 tablets (PTP 10 tablets x 10). Mfd. by Sanwa Kagaku Kenkyusho Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥27,600
10 - 19 12% JPY ¥26,400
20 + 18% JPY ¥24,600
SKU: MET-100500-TAB Category:

Description

Product Overview / 商品概要

Metoana Combination Tablets HD (Anagliptin 100mg / Metformin Hydrochloride 500mg) (メトアナ配合錠HD)
Generic: Anagliptin / Metformin Hydrochloride / アナグリプチン・メトホルミン塩酸塩
Therapeutic Category: Selective DPP-4 Inhibitor / Biguanide Combination Agent – Type 2 Diabetes Treatment / 選択的DPP-4阻害剤/ビグアナイド系薬剤配合剤 ―2型糖尿病治療剤―
Manufactured by: Sanwa Kagaku Kenkyusho Co., Ltd. / 株式会社三和化学研究所

Composition & Specification / 組成・規格

Active Ingredient: Anagliptin 100mg / Metformin Hydrochloride (JP) 500mg per tablet / 1錠中アナグリプチン100mg/「日局」メトホルミン塩酸塩500mg
Additives: Alpha-cyclodextrin, Microcrystalline cellulose, Crospovidone, Hydroxypropylcellulose, Hypromellose, Yellow ferric oxide, Titanium oxide, Magnesium stearate, Macrogol 6000, Carnauba wax / α-シクロデキストリン、結晶セルロース、クロスポビドン、ヒドロキシプロピルセルロース、ヒプロメロース、黄色三二酸化鉄、酸化チタン、ステアリン酸Mg、マクロゴール6000、カルナウバロウ
Appearance: Oval, pale yellow film-coated tablet. Major axis: 18.2mm, minor axis: 7.7mm, thickness: 6.4mm, weight: 710mg. Identification code: Sc150
外観: 楕円の淡黄色のフィルムコーティング錠。長径18.2mm、短径7.7mm、厚さ6.4mm、重量710mg。識別コード:Sc150

Indications / 効能効果

EN: Type 2 diabetes mellitus, only when combination therapy with anagliptin and metformin hydrochloride is considered appropriate.
JA: 2型糖尿病。ただし、アナグリプチン及びメトホルミン塩酸塩の併用による治療が適切と判断される場合に限る。

Dosage and Administration / 用法用量

EN: Usually, administer 1 tablet (anagliptin/metformin hydrochloride 100mg/500mg) orally twice daily, in the morning and evening.
JA: 通常、成人には1回1錠(アナグリプチン/メトホルミン塩酸塩として100mg/500mg)を1日2回朝夕に経口投与する。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product or biguanide agents / Patients with a history of lactic acidosis / Patients with severe renal impairment (eGFR <30mL/min/1.73m2) or on dialysis / Patients with severe hepatic impairment / Patients with serious cardiovascular or pulmonary dysfunction or other conditions prone to hypoxemia / Patients with dehydration or at risk of dehydration / Excessive alcohol consumers / Patients with severe ketosis, diabetic coma or pre-coma, or type 1 diabetes / Patients with serious infections, perioperative patients, or patients with serious trauma / Patients with malnutrition, starvation, debilitation, hypopituitarism, or adrenal insufficiency / Pregnant women or women who may be pregnant
JA: 本剤の各成分又はビグアナイド系薬剤に対し過敏症の既往歴のある患者/乳酸アシドーシスの既往のある患者/重度の腎機能障害(eGFR30mL/min/1.73m2未満)のある患者又は透析患者/重度の肝機能障害のある患者/心血管系・肺機能に高度の障害のある患者及びその他の低酸素血症を伴いやすい状態にある患者/脱水症の患者又は脱水状態が懸念される患者/過度のアルコール摂取者/重症ケトーシス、糖尿病性昏睡又は前昏睡、1型糖尿病の患者/重症感染症、手術前後、重篤な外傷のある患者/栄養不良状態、飢餓状態、衰弱状態、脳下垂体機能不全又は副腎機能不全の患者/妊婦又は妊娠している可能性のある女性

Regulatory Information / 規制情報

Approval No.: 23000AMX00820000
Sales Started: November 2018 / 2018年11月
Classification Code: 873969
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 100 tablets (PTP 10 tablets x 10) / 100錠(PTP10錠×10)
Other Available Packages (by special order): 100 tablets (PTP 10 tablets x 10), 140 tablets (PTP 14 tablets x 10), 500 tablets (PTP 10 tablets x 50), 500 tablets (bulk, with desiccant)

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Anagliptin / Metformin Hydrochloride Tablets 100mg/500mg (Metoana HD® / メトアナ配合錠HD)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Anagliptin

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.